✦ LIBER ✦

PSY30 Cost Utility Analysis of the Profilaxis Versus On-Demand Treatment With Recombinant Factor IX for the Treatment of Hemophilia B in Mexico

✍ Scribed by E. Muciño-Ortega; V. Leyva-Bravo; C. Gutiérrez; R.M. Galindo-Suárez

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PRS20 A COST-UTILITY ANALYSIS ON THE USE

✍ F. García-Contreras; G. Zuñiga; B. Briones 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PMS46 Cost-Utility Analysis of Certolizu

✍ R. Villoro; A. Hidalgo; B. Ferro; P. Talavera 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Cost-utility analysis of rufinamide vers

✍ Lara Verdian; Yunni Yi 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 827 KB

PRS14 A COST-EFFECTIVENESS ANALYSIS ON T

✍ B. Briones; G. Zuñiga; F. García-Contreras 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PIN29 A COST-EFFECTIVENESS ANALYSIS ON T

✍ B. Briones; M. Martinez Revelles; F. García-Contreras 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

PIN26 A COST-EFFECTIVENESS ANALYSIS ON T

✍ F. García-Contreras; M. Martinez Revelles; B. Briones 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB